Type 2 Diabetes Modules – Module 3: Implementing NICE guideline 28 (NG28)

Online Course • AstraZeneca UK

About the CPD course

This comprehensive and interactive mini educational module; 20 mins in length; on Type 2 Diabetes (T2D) implementing NG28 guidelines is designed to focus on pharmacological treatment options for adults with T2D based on the NG28 update in June 2022. The HCP will progress through the module to fine-tune their skills in implementing the guidance in clinical practice. Users follow a visual and engaging pathway the module; with multiple choice questions at the beginning to assess their level of initial knowledge and then again at the end providing learner reflection of their knowledge.

CPD Provider

AstraZeneca UK

View Profile

Send an enquiry

Full Name*

Email Address*

Contact Number*

Industry*

Your Enquiry*

By submitting this form, you consent to CPD sending you email regarding your application.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

AstraZeneca UK

A global pharmaceutical company with a major UK presence. Our purpose is to push the boundaries of science to deliver life-changing medicines. The best way we can help patients is to be science-led and share this passion with the scientific, healthcare and business communities of the UK.